At NeuroMetrix, we believe that technology can empower people to reclaim their lives from chronic disease. Through our long-standing history and clinical expertise, we understand that by tapping into the power of the nervous system, we can affect disease without the side effects of drugs. Our mission is to improve health through technology – by investing in meaningful innovation and gathering data, we can use these insights to transform medicine.
Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology, NeuroMetrix is a commercial stage company that integrates neurostimulation and digital medicine innovations to address chronic health conditions including chronic pain, sleep disorders and diabetes.
Offering the millions of people who suffer from chronic pain a new wearable technology for pain control utilizing advanced neurotechnology.
Providing physicians the ability to test for diabetic neuropathy, the most common long term complication of Type 2 diabetes, accurately and rapidly at the point-of-care.
Helping patients optimize their therapy and decrease the impact of chronic pain on their quality of life.